Related Experiment Video
Updated: Jan 17, 2026

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing
Published on: October 16, 2018
Evaluating the impact of COVID-19 on the HIV epidemic among MSM in Australia
Rongxing Weng1, Jisoo A Kwon1, Mo Hammoud1
1Kirby Institute, UNSW Sydney.
Objective:
Government-imposed physical distancing restrictions during the COVID-19 pandemic disrupted biobehavioral HIV prevention practices and access to healthcare services. This study aimed to use a mathematical model to evaluate the impact of COVID-19 on the HIV epidemic among MSM in Australia, using empirical data.
Design:
A retrospective modeling study.
Methods:
We developed a mathematical model to estimate monthly HIV incidence between January 2020 and August 2022. We obtained aggregated monthly data for sexual partners, condom use, HIV testing, preexposure prophylaxis (PrEP) use, and migration. Three scenarios were simulated: a COVID-19 scenario; a no COVID-19 scenario where input parameters remained at pre-COVID-19 values; and a no COVID-19 scenario with continued PrEP scale-up.
Results:
In the absence of the COVID-19 pandemic, 1263 (95% percentile interval: 880-1706) infections would have occurred between January 2020 and August 2022 compared to 915 (95% percentile interval: 638-1282) for the COVID-19 scenario (a 27.6% reduction). Reduced sexual partners was the leading factor contributing to the change in HIV infections and diagnoses (-24.9 and -10.6%, respectively). MSM aged at least 50 years had a larger reduction (31.0%) in new HIV infections than their younger counterparts (19.9%).
Conclusion:
A substantial reduction in new HIV infections and diagnoses in Australia occurred during the COVID-19 pandemic, largely due to decreased numbers of sexual partners. This reduction underscores the need for sustained public health strategies leveraging reduced transmission rates to continue progress toward eliminating HIV in Australia.
Related Concept Videos
Sexually Transmitted Infections
Retrovirus Life Cycles
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Subviral Agents

